Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
RespiVert Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Respivert | Advent Life Sciences
Centocor Snaps Up Inhaled Respiratory Therapeutics Firm RespiVert
Therapeutic Agents for COPD and Steroid-Resistant Asthma
Respivent Respiratory therapy Prpducts
Respivent Products | Respiratory Medical systems
Respivent (2 Pouches) • Dexa Group
JNJ's biotech unit buys British company targeting asthma - nj.com
Rationale of the Combined Use of Inspiratory and Expiratory Devices in ...
Pulmonary Fibrosis Therapy Developer Pulmatrix Obtains Rights to ...
Clinical Project Management Services | Niche
INHALERS – Test Strip Center
Asthma Medications - MN Dept. of Health
COMBIVENT RESPIMAT- ipratropium bromide and albuterol spray, metered
COPD Treatment | COMBIVENT RESPIMAT®
Nursing Update on New COPD Inhaler Devices – Part 1 Respimat® - AlixaRx ...
Frontiers | Half a Century of Technological Advances in Pulmonary Drug ...
BI confirms new inhaler technology for PBS - BioPharmaDispatch
Using your Respimat Inhaler | COMBIVENT RESPIMAT®
Implantable & Non-Implantable Drug Delivery Devices
In vitro dose comparison of RespimatR inhaler with dry powder inhalers ...
(PDF) Inhaled vaccine delivery in the combat against respiratory ...
About Combivent | Combivent® Respimat® Inhalation Spray
Pulmatrix Licenses Novel Drug Candidates from Janssen Subsidiary ...
Propeller Health Receives FDA Clearance for the Propeller Platform in ...
IS THERE A FUTURE FOR THE RESPIRATORY DELIVERY OF BIOLOGICS ...
PPT - New Drug Update 2011-2012 PowerPoint Presentation, free download ...
A Review of Non-Invasive Drug Delivery through Respiratory Routes
Pulmatrix inks licensing deal for novel inhaled kinase inhibitors ...
Combivent Inhaler Combivent Respimat: Package Insert / Prescribing
Patient Education | Combivent® Respimat® Inhalation Spray
P53: DUPILUMAB LEADS TO CLINICAL ASTHMA REMISSION INDICATIVE OF ...
Short introduction to Imperial Innovations | PPTX
Scientific Communications - Niche - Clinical Research Organisation ...
2020 Respiratory Drug Development eBook – Inhaled Medications for ...
Boehringer Ingleheim | King's John Price Paediatric Respiratory Conference
Boehringer Ingelheim to cap asthma and COPD inhalers | Asthma and ...
Reduktory Tlenowe - Reduktor do butli tlenowej - Medyczne - Cena ...
New therapeutic approach for advanced lung disease
Stephen Knight, SOM & MED ’90 | Yale Ventures
Johnson & Johnson | Administration and support services | Imperial ...
Pulamatrix Soars on News of Licensing Agreement with Johnson & Johnson ...
Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC ...
Pharmacology Flashcards Flashcards | Quizlet
Stephen Knight, MD - F-Prime Capital
Pulmonary drug delivery - Clinical GateClinical Gate
Advances in asthma-COPD overlap treatment: A comprehensive review of ...
PIPELINE TRENDS AND CHALLENGES IN PULMONARY DELIVERY | ONdrugDelivery
Imperial Innovations is helping one college profit from discovery
Figure 3 from Respimat as the new standard for inhalation therapy ...
How to become a biotechnology entrepreneur – Garth Rapeport
Strategies to Overcome Biological Barriers Associated with Pulmonary ...
BindingDB BDBM50026612 BIBF-1120::Nintedanib::US10981896, Compound ...
Lisa Pierre - VP Clinical Development at Sitryx Therapeutics | The Org
Numerical and Experimental Investigation on Key Parameters of the ...
Inhalers
Lessons from LAVOLTA - The Lancet Respiratory Medicine
New therapeutics promise respite to patients suffering from COPD ...
PPT - Influenza Antivirals: Challenges and Future Directions PowerPoint ...
Treating asthma exacerbations in athletes: TUE or not TUE? - The Lancet ...
Patient-centred, Planet-friendly: The propellant-free, metal-free ...
Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and ...
All subsidiary companies of the Johnson & Johnson group (Nyse ...
New perspectives in nanotherapeutics for chronic respiratory diseases - PMC
Science & Technology – Respira Therapeutics
Respiratory Therapeutics Group Respivent Hme 1000 With Filter Sample ...
Allergenprovokations-Tests in der AIT Stand der Technik
(PDF) Clinical effectiveness of the Respimat inhaler device in managing ...
Amelioration in Approaches for Enhanced Pulmonary Drug Delivery | Open ...
(PDF) The Respimat® Soft Mist Inhaler: Implications of Drug Delivery ...
Mepolizumab, quality of life, and severe eosinophilic asthma - The ...
Presentation COPD.pptx
COPD Information and Trials
Making Sense of New Inhaled Therapies in COPD
(PDF) 874. Hepatocellular Morphology in the Pahenu2 Mouse Model of PKU ...
Dr Stephen Collingwood – Enterprise Therapeutics
Profile of the Respimat soft mist inhaler for chronic obstructive ...
76 & 77: Drugs Respiratory Flashcards | Quizlet
(PDF) 877. Evidence for Dominant-Negative Interference in the Pahenu2 ...
Garth Rapeport - F-Prime Capital
Inhaler therapy for COPD. An individualised approach to inhaler ...
Patient perceptions of the re-usable Respimat® Soft Mist™ inhaler in ...
Shahzad Malik | Advent Life Sciences
Inhaler therapy for COPD: an individualised approach to inhaler ...
Boehringer Ingelheim Korea initiates voluntary recall for COPD and ...
Inhaler Education – INHALE
Our Team – LoQus23 Therapeutics
| PPA | Dove Medical Press
(PDF) In vitro dose comparison of Respimat® inhaler with dry powder ...
(PDF) 879. Morphologic and Immunohistochemical Evaluation of ...
Kate Bingham - SV Health Investors
Frontiers | Update on Long-Acting Anticholinergics in Children and ...
Inhaler Guide — Manitoba
Nueva alternativa terapéutica para frenar el avance de la EPOC
Company - Highlight Therapeutics
Latest Key Approvals and Alerts in Primary Care
Slide 4
30132-7/asset/e6b46508-07ba-4d9d-8e31-5d9065bba214/main.assets/fx1.jpg)
